Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: AroCell: TPS CLIA Receives Approval For Use On Fosun Diagnostics' Fully Automated System In China

May 31 (Reuters) - AroCell AB (publ)  AROC.ST :
    * TPS CLIA HAS RECEIVED APPROVAL FOR USE ON FOSUN
DIAGNOSTICS'
FULLY AUTOMATED SYSTEM IN CHINA
    * PARTNER, ZECEN BIOTECH, HAS RECEIVED REGISTRATION
CERTIFICATE
FROM CHINESE REGISTRATION AUTHORITIES NMPA
    * TPS CLIA IS NOW ALSO APPROVED FOR USE ON FOSUN
DIAGNOSTICS'
FULLY AUTOMATED CLIA PLATFORMS IN CHINA.

Source text for Eikon:  ID:nMFNbSwfjN 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on IDL Diagnostics AB (publ)

See all news